Zimmer Biomet Enters Partnership To Improve Outcomes For Patients With Fragile Hip Fractures
Zimmer Biomet announced today it entered into a partnership with the European Pathway Association, a not-for-profit group that evaluates care pathways, to study patients with fragile hip fractures, understand the care process, and improve outcomes.
You may also be interested in...
The worldwide joint-replacement implants market is expected to hit $20bn by 2022, according to a new report from Meddevicetracker. The growth is driven by the rising number of elderly patients, whose natural joints have been damaged by arthritis, and the rising prevalence of chronic diseases, such as obesity and diabetes, and sport-related injuries. But a look at the market and the three largest segments – shoulder, knee and hip replacements – show that new technological advancements and improved surgical techniques are increasingly making joint replacement surgeries an option for younger people as well. Here's an overview and key insights from two orthopedic surgeons on the current market and key growth drivers and limiters.
Of thousands of health apps, including femtech apps, reviewed by ORCHA, only 20% meet the required standards to be considered “trustworthy.”
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights AI trends in medtech, Exec Chats with iRhythm and medical robotics authority Moshe Shoham, and key FDA updates.